nPhase
AI-native clinical data platform connecting trial data from capture to regulatory submission
About
nPhase is a clinical research technology company based in Atlantic Beach, Florida. Its enterprise platform, nPhase.ai, unifies a Unified Data Management System (UDMS) and a Statistical Computing Environment (SCE) to connect the clinical data lifecycle from study startup through regulatory submission for pharmaceutical sponsors and CROs, with continuous data ingestion, near-real-time validation and AI agents working under human oversight. It also offers REDCap Cloud, an EDC platform for small and mid-size sponsors, academic and nonprofit research, MedTech and real-world data programs. In November 2026 nPhase closed a $30 million Series D led by Viking Global Investors, its first equity raise since 2017.
- Website
- nphase.ai
- Location
- Atlantic Beach, Florida, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- nPhase SCE — Statistical computing environment that turns study data into submission-ready datasets · Saas
- nPhase UDMS — Unified clinical data management from capture and integration to cleaning and analytics · Saas
- REDCap Cloud — Clinical research platform with EDC, ePRO and eConsent in one solution · Saas